A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects
NCT03028246
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Benign Centrally-Located Intracranial Tumors
Interventions
DEVICE:
ExAblate 4000 System
Sponsor
InSightec